Clenoliximab

Clenoliximab (INN^[1]) is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis.^[2] The drug is a chimeric antibody from Macaca irus and Homo sapiens.^[1]

Clenoliximab

Monoclonal antibody
Type	Whole antibody
Source	Chimeric (primate/human)
Target	CD4
Clinical data
ATC code	none
Identifiers
CAS Number	182912-58-9 Y
DrugBank	DB06241 Y
ChemSpider	none
UNII	78EVW7GX37
NY (what is this?)  (verify)